Filing Details

Accession Number:
0001493152-23-005076
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-14 19:13:37
Reporting Period:
2023-02-10
Accepted Time:
2023-02-14 19:13:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1695357 Provention Bio Inc. PRVB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1493714 Ashleigh Palmer C/O Provention Bio, Inc.
55 Broad Street, 2Nd Floor
Red Bank NJ 07701
Director And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-02-10 50,000 $2.50 2,620,050 No 4 M Direct
Common Stock Disposition 2023-02-10 50,000 $10.11 2,570,050 No 4 S Direct
Common Stock Acquisiton 2023-02-13 25,835 $2.50 2,595,885 No 4 M Direct
Common Stock Disposition 2023-02-13 25,835 $10.04 2,570,050 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2023-02-10 50,000 $0.00 50,000 $2.50
Common Stock Stock Option (right to buy) Disposition 2023-02-13 25,835 $0.00 25,835 $2.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
467,555 2027-04-25 No 4 M Direct
441,720 2027-04-25 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.28 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.42 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  4. The option is fully vested.